Efficacy of Facial Massager in Reducing Intra Oral Injection Pain in Pediatric Patients

June 26, 2026 updated by: Jaya chandra Reddy Bhumireddy, Government Dental College and Hospital, India

Efficacy of a Vibrating Facial-T- Massager as an Adjunct to Topical Anesthesia in Reducing Intraoral Injection Pain in Children: A Randomized Controlled Trial.

Abstract

  • Background: Local anesthesia is a primary source of anxiety in pediatric dentistry.
  • Objective: To evaluate if mechanical vibration from a low-cost facial massager reduces pain and anxiety during injections using the Gate Control Theory.
  • Design: Prospective Randomized Controlled Trial .

Study Overview

Status

Not yet recruiting

Detailed Description

Methodology & Study Design

  • Setting: Pediatric Dental Department, Kadapa, Andhra Pradesh.
  • Inclusion Criteria: Children aged 4-12 years requiring local anesthesia, cooperative (frankl 3,4)
  • Exclusion Criteria: History of allergy to benzocaine, acute infection at the site, or special healthcare needs affecting sensory perception, Medically compromised, unco-operative children, those who do not consent.

Intervention Protocol

  1. Group 1: Application of 20% Benzocaine gel for 2 minutes followed by a standard local anesthetic injection.
  2. Group 2: Application of Facial Massager on the buccal mucosa 30 seconds prior to and during the injection.
  3. Group 3: Application of 20% Benzocaine gel for 2 minutes + Facial Massager applied to the buccal mucosa 30 seconds prior to and during the injection.
  4. Infection Control & Sterilization

To ensure patient safety, the following protocol for the non-medical T-massager will be implemented:

  • Barrier Protection: The device will be encased in a single-use, disposable polyethylene sleeve (Digital Sensor Sleeve) and secured with tape.
  • Disinfection: After barrier removal, a "Double-Wipe" method using 70% Isopropyl Alcohol wipe will be used.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 4-12 years requiring local anesthesia
  • Cooperative behaviour (frankl rating 3,4)

Exclusion Criteria:

  • History of allergy to benzocaine
  • acute infection at the site
  • special healthcare needs affecting sensory perception
  • Medically compromised children
  • unco-operative children
  • those who do not consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: benzocaine group
20% topical benzocaine
topical application of mucopain gel for 30 seconds
Experimental: vibrating T massager
Facial T Massager producing local vibration on mucosal application
vibrating facial T massager used to apply on mucosa for mechanical stimulation and gate control
Experimental: combination
combination of benzocaine and massager
topical application of mucopain gel for 30 seconds
vibrating facial T massager used to apply on mucosa for mechanical stimulation and gate control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self reort of pain
Time Frame: after injection
wong-baker faces pain rating scale with face emoji rating no pain as score zero to score ten as that huts worst.
after injection

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physiologic parameter
Time Frame: pre and during administration of local anesthesia
measuring heart rate pre and during injection of local Anesthesia
pre and during administration of local anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 26, 2026

First Posted (Actual)

July 2, 2026

Study Record Updates

Last Update Posted (Actual)

July 2, 2026

Last Update Submitted That Met QC Criteria

June 26, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • pr.69/IEC/GDCH/KDP/2025-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share individual participant data. The aggregated, analyzed results of this clinical trial comparing the intraoral massager and benzocaine gel will be disseminated via publication in a peer-reviewed scientific journal.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Local Anesthesia Infiltration

Clinical Trials on Topical Benzocaine 20%

3
Subscribe